Literature DB >> 3046451

The corporate compromise: a Marxist view of health maintenance organizations and prospective payment.

D U Himmelstein1, S Woolhandler.   

Abstract

Recent developments in health care are strikingly congruent with a Marxist paradigm. For many years small scale owner producers (physicians) dominated medicine, and the corporate class supported the expansion of services. As health care expanded, corporate involvement in the direct provision of services emerged. This involvement is reflected not only in the rise of for-profit providers, but also in the influence of hospital administrators, utilization review organizations, insurance bureaucrats, and other functionaries unfamiliar with the clinical encounter, but well versed on the bottom line. Corporate providers' quest for increasing revenues has brought them into conflict with corporate purchasers of care, whose employee benefit costs have skyrocketed. This intercorporate conflict powerfully shapes health policy and has caused the rapid proliferation of health maintenance organizations and other forms of prospective payment. Corporate purchasers of care favor the incentives under prospective payment for providers to curtail care and its costs. For corporate providers, prospective payment has allowed increased profits even in the face of constrained revenues, because reimbursement is disconnected from resource use. Unfortunately, this corporate compromise serves patients and physicians poorly. Alternative policy options that challenge corporate interests could save money while improving care.

Entities:  

Mesh:

Year:  1988        PMID: 3046451     DOI: 10.7326/0003-4819-109-6-494

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  2 in total

1.  The quality of ambulatory care in Medicare health maintenance organizations.

Authors:  S M Retchin; B Brown
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

2.  Consultant episodes.

Authors:  A M Pollock; A Majeed
Journal:  BMJ       Date:  1993-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.